{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:26:31Z","timestamp":1769577991696,"version":"3.49.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:p>We report the first documented case of concurrent remission of chronic plaque psoriasis and pouchitis with tildrakizumab therapy. A 66-year-old man achieved sustained psoriasis clearance and pouchitis improvement following interleukin (IL)-23p19 inhibition, after an inadequate response to ultraviolet therapy, ciclosporin and adalimumab. This case highlights the potential role of selective IL-23 blockade in managing coexisting immune-mediated inflammatory conditions.<\/jats:p>","DOI":"10.1093\/ced\/llaf468","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:22:58Z","timestamp":1761222178000},"page":"313-314","source":"Crossref","is-referenced-by-count":0,"title":["Dual control of chronic plaque psoriasis and pouchitis with tildrakizumab"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0831-8021","authenticated-orcid":false,"given":"Aalia","family":"Syed","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of New South Wales , Sydney, NSW ,","place":["Australia"]},{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-9726","authenticated-orcid":false,"given":"Sera","family":"Sarsam","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales , Sydney, NSW ,","place":["Australia"]},{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"D\u00e9d\u00e9e\u00a0F","family":"Murrell","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales , Sydney, NSW ,","place":["Australia"]},{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"2026012711330058600_llaf468-B1","doi-asserted-by":"crossref","first-page":"983902","DOI":"10.1155\/2013\/983902","article-title":"Correlations between psoriasis and inflammatory bowel diseases","volume":"2013","author":"Skroza","year":"2013","journal-title":"Biomed Res Int"},{"issue":"Suppl 2","key":"2026012711330058600_llaf468-B2","doi-asserted-by":"crossref","first-page":"ii20","DOI":"10.1093\/ecco-jcc\/jjac023","article-title":"What can IBD specialists learn from IL-23 trials in dermatology?","volume":"16","author":"Valenti","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026012711330058600_llaf468-B3","doi-asserted-by":"crossref","first-page":"17562848251316412","DOI":"10.1177\/17562848251316412","article-title":"Pouchitis unveiled: exploring clinical features, diagnosis, and cutting-edge treatments","volume":"18","author":"Lusetti","year":"2025","journal-title":"Ther Adv Gastroenterol"},{"key":"2026012711330058600_llaf468-B4","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.3748\/wjg.v21.i29.8739","article-title":"Inflammatory pouch disease: the spectrum of pouchitis","volume":"21","author":"Zezos","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026012711330058600_llaf468-B5","doi-asserted-by":"crossref","first-page":"17562848241299564","DOI":"10.1177\/17562848241299564","article-title":"Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12\/23 and anti-IL-23 antibodies","volume":"17","author":"Bezzio","year":"2024","journal-title":"Ther Adv Gastroenterol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf468\/64926965\/llaf468.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/313\/64926965\/llaf468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/313\/64926965\/llaf468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:33:07Z","timestamp":1769531587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/2\/313\/8301108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,24]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf468","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,24]]}}}